Progensa PCA3 Assay
FDA premarket approval P100033/S008 · decided 2018-03-07
Approval details
- PMA number
- P100033
- Supplement
- S008
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Progensa PCA3 Assay
- Generic name
- Prostrate cancer genes nucleic acid amplification test system
- Applicant
- Gen-Probe Incorporated
- Date received
- 2018-02-08
- Decision date
- 2018-03-07
- Days to decision
- 27 days
- Decision code
- OK30
- Product code
- OYM
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- San Diego, CA
- Statement
- Change of subcomponent manufacturing location.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| APTIMA TRICHOMONAS VAGINALIS ASSAY (DEN110012) | Gen-Probe Incorporated | 2011-04-19 |